Biora Therapeutics Announced The Issuance Of A New Patent And The Allowance Of A Patent Application Related To Its BioJet Platform, Which Uses An Ingestible Device Designed To Achieve Systemic Uptake Through Liquid Jet Delivery To The Small Intestine
Portfolio Pulse from Benzinga Newsdesk
Biora Therapeutics has announced the issuance of a new patent and the allowance of a patent application related to its BioJet platform. The platform uses an ingestible device designed to achieve systemic uptake through liquid jet delivery to the small intestine.
August 04, 2023 | 1:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The issuance of a new patent and the allowance of a patent application for Biora Therapeutics' BioJet platform could potentially strengthen the company's intellectual property portfolio and competitive position in the market.
Patents provide companies with a competitive edge by preventing others from copying their technology. This new patent for Biora's BioJet platform could potentially enhance the company's market position by strengthening its intellectual property portfolio. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100